La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Gentherm a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Gentherm..

Gentherm (NASDAQ:THRM) Azioni, Catena delle Opzioni

Gentherm

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Gentherm Inc

<p>Craig-Hallum  analyst Ryan Sigdahl   maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Buy and lowers the price target from $85 to $65.</p>


News

Price Target

Analyst Ratings

THRM

Craig-Hallum Maintains Buy on Gentherm, Lowers Price Target to $65

<p>Baird  analyst Luke Junk   maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Neutral and lowers the price target from $54 to $50.</p>


Baird Maintains Neutral on Gentherm, Lowers Price Target to $50

<p><strong>Guidance</strong><br /><br />The Company's full-year 2024 guidance as of October 30, 2024 is shown below:</p>
<p><figure class="table"><br />
<table>
<tbody>
<tr>
<td><strong>As of July 31, 2024</strong></td>
<td><strong>As of October 30, 2024</strong>(1)</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Product Revenues</td>
<td>Low end of $1.5B – $1.6B</td>
<td>$1.45B – $1.47B</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Adjusted EBITDA Margin Rate</td>
<td>Above mid-point of 12.5% – 13.5%</td>
<td>Near mid-point of 12.5% – 13.5%</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Full-year Adjusted Effective Tax Rate</td>
<td>26% – 29%</td>
<td>No change</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Capital Expenditures</td>
<td>$65M – $75M</td>
<td>No change</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="4">(1)&nbsp;<i>Based on the current forecast of customer orders, our expectations of near-term conditions, and light vehicle production in our relevant markets decreasing at low to mid-single digit rate for full year 2024 versus 2023, and a EUR to USD exchange rate of $1.08/Euro.</i></td>
</tr>
</tbody>
</table>
<p></p></figure></p>


Guidance

Gentherm 2024 Outlook: Sees Revenue Of $1.45B–$1.47B (Prior $1.5B-$1.6B) Vs. $1.50B Est

Earnings

Earnings Beats

Earnings Misses

Gentherm Q3 2024 Adj. EPS $0.75 Beats $0.66 Estimate, Sales $371.512M Miss $373.676M Estimate

<p>Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) will release its quarterly earnings report on Wednesday, 2024-10-30. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Gentherm to report an <strong>earnings per share</strong> (EPS) of $0.66.</p>
<p>Anticipation surrounds Gentherm's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>The company's EPS beat by $0.05 in the last quarter, leading to a 1.96% drop in the share price on the following day.</p>
<p>Here's a look at Gentherm's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.61</td>
<td>0.43</td>
<td>0.52</td>
<td>0.68</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.66</td>
<td>0.62</td>
<td>0.90</td>
<td>0.64</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>3.0%</td>
<td>-1.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730228486_0.png" alt="eps graph" /></p>
<h3>Performance of Gentherm Shares</h3>
<p>Shares of Gentherm were trading at $41.7 as of October 28. Over the last 52-week period, shares are up 5.48%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analysts' Take on Gentherm</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Gentherm.</p>
<p>Analysts have given Gentherm a total of 1 ratings, with the consensus rating being Neutral. The average one-year price target is $56.0, indicating a potential 34.29% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of XPEL, Dana and Fox Factory Hldg, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for XPEL, with an average 1-year price target of $58.0, suggesting a potential 39.09% upside.</li>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Dana, with an average 1-year price target of $13.33, implying a potential 68.03% downside.</li>
<li>As per analysts' assessments, Fox Factory Hldg is favoring an Neutral trajectory, with an average 1-year price target of $46.75, suggesting a potential 12.11% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for XPEL, Dana and Fox Factory Hldg, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gentherm</td>
<td>Neutral</td>
<td>0.90%</td>
<td>$96.70M</td>
<td>2.93%</td>
</tr>
<tr>
<td>XPEL</td>
<td>Buy</td>
<td>7.51%</td>
<td>$47.87M</td>
<td>7.74%</td>
</tr>
<tr>
<td>Dana</td>
<td>Neutral</td>
<td>-0.36%</td>
<td>$255M</td>
<td>1.06%</td>
</tr>
<tr>
<td>Fox Factory Hldg</td>
<td>Neutral</td>
<td>-13.03%</td>
<td>$110.96M</td>
<td>0.45%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Gentherm is positioned in the middle among its peers for revenue growth, with one peer showing the highest growth rate. In terms of gross profit, Gentherm ranks second highest. However, Gentherm has the highest return on equity compared to its peers.</p>
<h3>About Gentherm</h3>
<p>Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.</p>
<h3>Breaking Down Gentherm's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Gentherm showcased positive performance, achieving a revenue growth rate of <strong>0.9%</strong> as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Gentherm's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>5.02%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Gentherm's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>2.93%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Gentherm's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>1.51%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Gentherm's debt-to-equity ratio is below the industry average at <strong>0.39</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/THRM/earnings"><strong>To track all earnings releases for Gentherm visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview: Gentherm

<p>JP Morgan  analyst Ryan Brinkman   upgrades Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) from Underweight to Neutral and maintains the price target from $56 to $56.</p>


Upgrades

JP Morgan Upgrades Gentherm to Neutral, Maintains Price Target to $56

<p>Effective September 1, 2024; Anversa To Join Logitech International As CFO</p>


Management

LOGI

Gentherm Announces Resignation Of CFO Matteo Anversa

<p><strong>Guidance</strong></p>
<p>The Company&#39;s full-year 2024&nbsp;guidance&nbsp;as of July 31, 2024 is shown below:</p>
<table align="center">
<tbody>
<tr>
<td><strong>Initial 2024&nbsp;Guidance</strong></td>
<td><strong>Latest Estimate</strong>(1)</td>
</tr>
<tr>
<td>Product Revenues</td>
<td>$1.5B&nbsp;&ndash;&nbsp;$1.6B</td>
<td>Low end of range</td>
</tr>
<tr>
<td>Adjusted EBITDA Margin Rate</td>
<td>12.5%&nbsp;&ndash;&nbsp;13.5%</td>
<td>Above mid-point of range</td>
</tr>
<tr>
<td>Full-year Adjusted Effective Tax Rate</td>
<td>26%&nbsp;&ndash;&nbsp;29%</td>
<td>No change</td>
</tr>
<tr>
<td>Capital Expenditures</td>
<td>$65M&nbsp;&ndash;&nbsp;$75M</td>
<td>No change</td>
</tr>
<tr>
		</tr>
<tr>
<td colspan="4"><em>(1) Based on the current forecast of customer orders, and light vehicle production in the Company&#39;s key markets declining at a low single digit rate in 2024 versus 2023, and a EUR to USD exchange rate of&nbsp;$1.08/Euro for the remainder of the year.</em></td>
</tr>
</tbody>
</table>


Gentherm 2024 Outlook: Sees Revenue Of $1.5b-$1.6b Vs. $1.527b Est.; And Adjusted EBITDA Margin Of 12.5%-13.5%

<p>Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.61 by 8.2 percent. This is a 13.79 percent increase over earnings of $0.58 per share from the same period last year.  The company reported quarterly sales of $375.683 million which beat the analyst consensus estimate of $374.152 million by 0.41 percent.  This is a 0.90 percent increase over sales of $372.323 million the same period last year.</p>


Gentherm Q2 2024 Adj. EPS $0.66 Beats $0.61 Estimate, Sales $375.683M Beat $374.152M Estimate

<p>JP Morgan  analyst Ryan Brinkman   maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Underweight and lowers the price target from $60 to $56.</p>


JP Morgan Maintains Underweight on Gentherm, Lowers Price Target to $56

<p>Baird  analyst Luke Junk   maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Neutral and lowers the price target from $65 to $60.</p>


Baird Maintains Neutral on Gentherm, Lowers Price Target to $60

<p><strong>Cognizant Technology Solutions</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctsh#NASDAQ">CTSH</a>) benefits from an expanding portfolio with the recent launch of Neuro Edge, a new platform in its Neuro suite.</p>
<p>The solution empowers businesses across industries to harness the power of edge AI, enabling real-time decision-making and operational efficiency while reducing dependency on centralized servers and the cloud.</p>
<p>Neuro Edge supports a hybrid Cloud + Edge AI approach, ensuring data privacy, security and seamless integration with existing IT environments.</p>
<p>With applications spanning healthcare, manufacturing, retail, automotive and more, Cognizant is poised to transform enterprise capabilities in AI-driven edge computing.</p>
<h3>Cognizant&#39;s Prospects Driven by Strong Partner Base</h3>
<p>The latest move bodes well with CTSH&#39;s focus on enhancing AI capabilities and providing industry-specific solutions through the Cognizant Neuro Edge platform.</p>
<p>Further expanding its portfolio, Cognizant recently announced an agreement with Texas Dow Employees Credit Union (TDECU) to leverage its AI-driven Neuro IT Operations platform for enhancing operational efficiency, resilience and customer experience in TDECU&#39;s transformation journey.</p>
<p>Cognizant&#39;s robust partner base, which includes the likes of <strong>Gentherm</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>), <strong>Microsoft</strong>&nbsp;and <strong>CNO Financial Group</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>), is a critical catalyst. Its robust pipeline, which includes a favorable mix of new opportunities, is noteworthy.</p>
<p>In first-quarter 2024, CTSH demonstrated significant improvement in securing large deals, winning several contracts worth more than $100 million each.</p>
<p>The company recently collaborated with Gentherm to provide engineering services, including systems engineering, validation and model-based development, aiming to enhance agility and scalability in product development through cloud-native technologies and virtualization.</p>
<p>In April, Cognizant, in collaboration with Microsoft, announced an expanded partnership aiming to leverage generative AI and Copilots to drive innovation across industries, focusing on transforming enterprise operations and enhancing employee experiences.</p>
<p>In first-quarter 2024 Cognizant announced the continuation of its partnership with CNO Financial, a leading provider of insurance, financial services, and workforce benefits solutions to middle-income America. Cognizant will help in optimizing and enhancing CNO Financials&#39; technology-based services and solutions with cloud and digital technologies.</p>
<h3>Conclusion</h3>
<p>Despite an expanding portfolio and a strong partner base, weakness in the Financial Services segment negatively impacted Cognizant&#39;s top line.</p>
<p>In first-quarter 2024, revenues of $4.76 billion saw a year-over-year decline of 1.1% and 1.2% at constant currency (cc). The Financial Services revenues dropped 6.2% year over year to $1.38 billion during this period.</p>
<p>The company&#39;s shares have declined 10.3% against the Zacks Computer &amp; Technology sector&#39;s growth of 24.5% year to date.</p>
<p>This Zacks Rank #2 (Buy) company expects second-quarter 2024 revenues to be between $4.75 billion and $4.82 billion, indicating a decline of 2.9% to 1.4% (a decline of 2.5-1% at cc).</p>
<p>The Zacks Consensus Estimate for second-quarter revenues is pegged at $4.81 billion, indicating a decline of 1.63% from year-ago levels.</p>
<p>The consensus mark for earnings is pegged at $1.12 per share, unchanged in the past 30 days.</p>
<p><a href="https://www.zacks.com/stock/news/2296262/cognizant-ctsh-expands-neuro-suite-with-edge-ai-platform?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2296262">To read this article on Zacks.com click here.</a></p>


Small Cap

Markets

Tech

Trading Ideas

CTSH

Cognizant Expands Neuro Suite With Edge AI Platform

<p><em>Agreement expected to help develop next generation of innovative products, elevate customer vehicle experiences, and improve everyday life</em></p>
<p>TEANECK, N.J., June 17, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4191420-1&amp;h=3144140095&amp;u=https%3A%2F%2Fwww.cognizant.com%2Fus%2Fen&amp;a=Cognizant">Cognizant</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSH#NASDAQ">CTSH</a>) today announced an agreement to provide engineering services to Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Cognizant is providing systems engineering, validation, and model-based development services from Hyderabad, India, and has created a test facility to conduct research and development for Gentherm products.</p>


Cognizant, Gentherm Sign Agreement For Strategic Product Engineering Services And Development Of A New Delivery Center

Buybacks

Gentherm Announces $150M Stock Repurchase Program Authorized By Board Of Directors

<p>Baird  analyst Luke Junk   maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Neutral and lowers the price target from $67 to $65.</p>


Baird Maintains Neutral on Gentherm, Lowers Price Target to $65

WIIM

Gentherm shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and issued guidance.

Gentherm Sees FY24 Revenue Of $1.5B - $1.6B Vs. $1.55B Est.

<p>Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.43 by 44.19 percent. This is a 26.53 percent increase over earnings of $0.49 per share from the same period last year.  The company reported quarterly sales of $356.01 million which missed the analyst consensus estimate of $358.53 million by 0.70 percent.  This is a 2.09 percent decrease over sales of $363.63 million the same period last year.</p>


Gentherm Q1 Adj $0.62 Beats $0.43 Estimate, Sales $356.01M Miss $358.53M Estimate

<p>Analysts' ratings for Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $61.75, a high estimate of $66.00, and a low estimate of $58.00. This current average reflects an increase of 2.92% from the previous average price target of $60.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1713798044_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of Gentherm among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$60.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$63.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Luke Junk</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$58.00</td>
<td>$59.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Gentherm. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Gentherm compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Gentherm's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Capture valuable insights into Gentherm's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/THRM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Gentherm analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind Gentherm</h2>
<p>Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.</p>
<h3>Financial Insights: Gentherm</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Gentherm displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately <strong>6.88%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>4.93%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Gentherm's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.77%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Gentherm's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>1.47%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.38</strong>, Gentherm adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


In-Depth Examination Of 4 Analyst Recommendations For Gentherm

<p>JP Morgan  analyst Ryan Brinkman   maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Underweight and lowers the price target from $63 to $60.</p>


JP Morgan Maintains Underweight on Gentherm, Lowers Price Target to $60

Gentherm (THRM) has provided an announcement. Gentherm Incorporated's CFO, Matteo Anversa, will step down on September 1, 2024, to take on a new op...

Gentherm Announces CFO Transition and Interim Successor

Warning: THRM is at high risk of performing badly

JPMorgan upgraded Gentherm (THRM) to Neutral from Underweight with an unchanged price target of $56. The firm cites "incremental attraction" to the...

Gentherm upgraded to Neutral from Underweight at JPMorgan

Craig-Hallum analyst Ryan Sigdahl maintained a Buy rating on Gentherm (THRM – Research Report) today. The company's shares closed last Friday at $4...

Craig-Hallum Keeps Their Buy Rating on Gentherm (THRM)

Gentherm Non-GAAP EPS of $0.75

Reports Q3 revenue $371.5M, consensus $373.68M. Phil Eyler, the company's President and CEO, said, "The financial and operating results of the thir...

Gentherm reports Q3 adjusted EPS 75c, consensus 66c

FY24 revenue consensus $1.5B. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See t...

Gentherm cuts FY24 product revenue view to $1.45B-$1.47B from $1.5B-$1.6B

Gentherm Incorporated (THRM) Q3 2024 Earnings Call Transcript

Gentherm Inc ( ($THRM) ) has realeased its Q3 earnings. Here is a breakdown of the information Gentherm Inc presented to its investors. Gentherm In...

Gentherm Inc. Reports Record New Business Awards and Revenue Growth

In a report released today, Glenn Chin from Seaport Global maintained a Buy rating on Gentherm (THRM – Research Report), with a price target of $68...

Seaport Global Sticks to Its Buy Rating for Gentherm (THRM)

Press Releases

Gentherm Announces New Stock Repurchase Authorization

Contracts

Cognizant and Gentherm Sign Agreement for Strategic Product Engineering Services and Development of a New Delivery Center

Gentherm Named 2024 Top North American Supplier by Honda

Gentherm Announces Date for 2024 Second Quarter Results News Release and Conference Call

Gentherm to Participate in J.P. Morgan Auto Conference

Gentherm Reports 2024 Second Quarter Results

Gentherm Announces Departure of its Chief Financial Officer

Gentherm Announces Date for 2024 Third Quarter Results News Release and Conference Call

Gentherm to Participate in the 2024 Baird Global Industrial Conference

Gentherm Reports 2024 Third Quarter Results

Adient

Autoliv

Aptiv

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Hldgs

BorgWarner

Dana

Dorman Prods

ECARX Holdings Inc. - Class A Ordinary shares

ECARX Holdings

Fox Factory Hldg

Gentex

Garrett Motion

Holley

Hesai Group - American Depositary Share, each ADS represents one Class B ordinary share

Comments

Gentherm

Gentherm (THRM) Opzioni

Gentherm (NASDAQ:THRM) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO